1. HIV/AIDS, J.U.N.P.o., Fact sheet: World AIDS Day 2019—global HIV statistics. 2019.
2. Kibret, G.D., et al., Trends and spatial distributions of HIV prevalence in Ethiopia. Infectious diseases of poverty, 2019. 8(1): p. 90.
3. Podlekareva, D., et al., Factors associated with the development of opportunistic infections in HIV-1–infected adults with high CD4+ cell counts: a EuroSIDA study. The Journal of infectious diseases, 2006. 194(5): p. 633-641.
4. Costaggiu, D., et al., Determination of neutral lipid and cluster formation for screening neurocognitive impairment in human immunodeficiency virus patients. Journal of AIDS and Clinical Research, 2015. 6(11).
5. Allais, S., The implementation and impact of National Qualifications Frameworks: Report of a study in 16 countries. 2010: ILO Geneva.
6. Edwards, L.A., Establishing a pastoral care ministry for those infected and affected by HIV/AIDS at the Robert Pinn Memorial Baptist Church. 2015, Eastern University.
7. Nissapatorn, V., et al., AIDS-related opportunistic infections in Hospital Kuala Lumpur. Japanese journal of infectious diseases, 2003. 56(5/6): p. 187-192.
8. Hogg, R.S., et al., Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Cmaj, 1999. 160(5): p. 659-665.
9. Inungu, J.N., E.D. Mokotoff, and J.B. Kent, Characteristics of HIV infection in patients fifty years or older in Michigan. AIDS patient care and STDs, 2001. 15(11): p. 567-573.
10. Mitiku, H., F. Weldegebreal, and Z. Teklemariam, Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia. HIV/AIDS (Auckland, NZ), 2015. 7: p. 137.
11. Eyasu, M., A. Berhane, and S. Yohannes, SPECTRUM AND ASSOCIATED RISK FACTORS OF OPPORTUNISTIC INFECTIONS AMONG ANTIRETROVIRAL THERAPY EXPERIENCED HIV/AIDS PATIENTS IN ADDIS ABABA, ETHIOPIA. Semantic Scholar, 2015.
12. Mekuria, L.A., et al., Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa. AIDS care, 2015. 27(8): p. 934-945.
13. Iroezindu, M., Disparities in the magnitude of human immunodeficiency virus-related opportunistic infections between high and low/middle-income countries: Is highly active antiretroviral therapy changing the trend? Annals of medical and health sciences research, 2016. 6(1): p. 4-18.
14. Low, A., et al., Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries: a systematic review and meta-analysis. Clinical infectious diseases, 2016. 62(12): p. 1595-1603.
15. Ingabire, P.M., et al., Delayed Antiretroviral Therapy (ART) Initiation among Hospitalized Adults in a Resource-Limited Settings: A Challenge to the Global Target of ART for 90 of HIV-Infected Individuals. AIDS research and treatment, 2019. 2019.
16. Moges, N. and G. Kassa, Prevalence of opportunistic infections and associated factors among HIV positive patients taking anti-retroviral therapy in DebreMarkos Referral Hospital, Northwest Ethiopia. J AIDs Clin Res, 2014. 5(5): p. 1-300.
17. Rubaihayo, J., et al., Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. BMC research notes, 2016. 9(1): p. 501.
18. Damtie, D., et al., Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC research notes, 2013. 6(1): p. 534.
19. Solomon, F.B., et al., Spectrum of opportunistic infections and associated factors among people living with HIV/AIDS in the era of highly active anti-retroviral treatment in Dawro Zone hospital: a retrospective study. BMC research notes, 2018. 11(1): p. 604.
20. Weldearegawi, T.Z., et al., The magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in southern zone Tigray, Ethiopia: a cross-sectional study. The Pan African Medical Journal, 2020. 35(126).
21. Dereje, N., et al., Prevalence And Predictors Of Opportunistic Infections Among HIV Positive Adults On Antiretroviral Therapy (On-ART) Versus Pre-ART In Addis Ababa, Ethiopia: A Comparative Cross-Sectional Study. Hiv/aids (Auckland, NZ), 2019. 11: p. 229.
22. Weldegebreal, T., et al., Magnitude of opportunistic diseases and their predictors among adult people living with HIV enrolled in care: national level cross sectional study, Ethiopia. BMC public health, 2018. 18(1): p. 820.
23. Xu, M., et al., Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla KPC, virulence factors and their impacts on clinical outcome. BMC infectious diseases, 2018. 18(1): p. 358.
24. (CSA), C.S.A.o.E. Mibraqawi Zone Census 2007 May, 2020; Available from: https://en.wikipedia.org/wiki/Mibraqawi_Zone.
25. Tigray regional health bureau. Ten years health bulletin (Ethiopia fiseal year 1998-2007). 2018.
26. Health, F.H.A.P.a.C.O.F.M.o., Managment of opportunistic infections and antiretroviral treatment in Adolescents and adults in Ethiopia. March, 2008.
27. WHO, Physical status: The use of and interpretation of anthropometry, Report of a WHO Expert Committee. 1995.
28. E, F.M.o.H., National Guideline for comprehensive HIV prevention, Care and treatment. 2014.
29. Morisky D.E., et al., Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension, 2008. 10(5): p. 348–354.
30. FMHACA, Standard Treatment Guidlines for General hospital. 2014: Addis Ababa.
31. Wachamo, D. and F. Bonja, Opportunistic Infections and Associated Factors among HIV/AIDS Patients taking Ante-Retroviral Therapy at Selected Hospitals in Sidama Zone, Southern Ethiopia: A facility-based cross-sectional study. 2019.
32. Iroezindu, M., et al., Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria. J AIDS Clin Res, 2013. 3: p. 002.